
Taiwan Pushes Ahead with Domestic Vaccines
More than two million doses of Medigen’s MVC-COV1901 have been administered domestically, but it has yet to gain traction internationally. Meanwhile UBI Pharma’s UB-612 is pending emergency-use authorization in Taiwan. Early in the coronavirus pandemic, Taiwan made a fateful decision: It would develop its own COVID-19 vaccines and make them a key part of its…